These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7297550)

  • 1. Analysis of phenylbutazone and its metabolites by high performance liquid chromatography.
    Taylor JB; Lees P; Gerring EL
    Equine Vet J; 1981 Jul; 13(3):201-3. PubMed ID: 7297550
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
    Bruce RB; Maynard WR; Dunning LK
    J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
    [No Abstract]   [Full Text] [Related]  

  • 4. HPLC method for the determination of 4-hydroxyphenylbutazone in phenylbutazone.
    Bulcsu H; Sándor G
    Acta Pharm Hung; 1980 Jul; 50(4):173-6. PubMed ID: 7270184
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance spectroscopic method for determination of phenylbutazone and oxyphenbutazone in tablets.
    Husain S; Kifayatullah M; Rao RN
    J Assoc Off Anal Chem; 1988; 71(3):525-7. PubMed ID: 3391955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Analysis of Phenylbutazone and Its Active Metabolite, Oxyphenbutazone, in Equine Tissues (Muscle, Kidney, and Liver), Urine, and Serum by LC-MS/MS.
    Boison JO; Dowling P; Matus JL; Kinar J; Johnson R
    J AOAC Int; 2017 Jul; 100(4):1110-1122. PubMed ID: 28145218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of phenylbutazone residues in horse tissues with and without enzyme-hydrolysis by LC-MS/MS.
    Boison JO; Dowling T; Johnson R; Kinar J
    Drug Test Anal; 2016 May; 8(5-6):535-8. PubMed ID: 27443208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of oxyphenbutazone and phenylbutazone by differential pulse polarography after derivatization.
    Fogg AG; Ahmed YZ
    Anal Chim Acta; 1977 Dec; 94(2):453-6. PubMed ID: 596627
    [No Abstract]   [Full Text] [Related]  

  • 10. Simultaneous high-performance liquid chromatographic determination of suxibuzone and its metabolites in plasma and urine.
    Marunaka T; Shibata T; Minami Y; Umeno Y; Shindo T
    J Pharm Sci; 1980 Nov; 69(11):1258-61. PubMed ID: 7452452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrophotometric determination of dipyrone, phenylbutazone and oxyphenbutazone by their hydrolysis and Schiff base formation with 4-dimethylaminobenzaldehyde.
    Verma KK; Jain A; Patel N; Sanghi SK
    Farmaco Prat; 1987 Jul; 42(7):185-92. PubMed ID: 3622752
    [No Abstract]   [Full Text] [Related]  

  • 12. [A simple and precise method for the analysis of phenylbutazone and oxyphenylbutazone by bromocoulometry].
    Nikolic KI; Velasevic KR; Ruasse MF
    Ann Pharm Fr; 1985; 43(2):173-6. PubMed ID: 4091460
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
    Caturla MC; Cusido E
    J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems.
    Woods WE; Weckman T; Blake JW; Tobin T
    J Pharmacol Methods; 1986 Dec; 16(4):297-313. PubMed ID: 3784574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of non-steroidal anti-inflammatory drugs residues in animal muscles by liquid chromatography-tandem mass spectrometry.
    Jedziniak P; Szprengier-Juszkiewicz T; Olejnik M; Zmudzki J
    Anal Chim Acta; 2010 Jul; 672(1-2):85-92. PubMed ID: 20579495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of phenylbutazone on eicosanoid levels in equine acute inflammatory exudate.
    Higgins AJ; Lees P; Taylor JB
    Cornell Vet; 1984 Jul; 74(3):198-207. PubMed ID: 6587959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
    Franssen MJ; Tan Y; Freij I; Van Ginneken CA; Gribnau FW
    Pharm Weekbl Sci; 1986 Aug; 8(4):229-33. PubMed ID: 3763367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
    Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
    Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.